Novozymes bags Organobalance
Denmark's Novozymes has acquired microbial research company Organobalance GmbH. The German company owns a large collection of microbial strains, some of which date back to the 1920s, and has strong capabilities in microbial screening and assay technology.
Germany-based Organobalance specializes in developing natural microbial solutions for customers and partners across a number of industries including food, feed, and animal health. Now, the company with a staff of 29 has been bought up by Danish industrial enzymes and microorganism expert Novozymes for an undisclosed amount.
The experience of Organobalance’s founding scientists, and the company’s know-how, immediately strengthen Novozymes’ existing capabilities within microbial technologies, says Sebastian Søderberg, Vice President for New Business Development, Incubation & Acquisitions at Novozymes. Organobalance will advance our understanding to develop new, sustainable solutions across industries, and provide us with additional commercial opportunities.
Organobalance co-founder Christine Lang will continue as General Manager. Lang commented: By becoming part of Novozymes, we will have access to a global R&D network and an extensive infrastructure to bring products to market – a clear advantage for us and our customers."
adobe stock photos - Sergii Figurnyi 
Laverock Therapeutics